Literature DB >> 19836016

The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Lisa C Grossman1, Konstantinos G Michalakis2, Hyacinth Browne2, Mark D Payson3, James H Segars4.   

Abstract

OBJECTIVE: To compare and contrast the pathophysiology of ovarian hyperstimualtion syndrome (OHSS) with known syndromes of increased intraabdominal pressure (IAP), and to explore the relationship of increased IAP with symptom severity in OHSS.
DESIGN: Literature review. MAIN OUTCOME MEASURE(S): Correlation of OHSS symptoms with IAP; effects of paracentesis on IAP in patients with OHSS.
SETTING: Academic Research Institution. INTERVENTION(S): None. RESULT(S): OHSS involves a rapid accumulation of volume (from 1.5-17 liters) in the peritoneal cavity that can lead to organ dysfunction, including respiratory impairment and oliguria. In published reports of 20 moderate-to-severe OHSS patients in whom IAP was measured, IAP was found to be elevated to a pathologic range. The increased IAP indicates that OHSS may be considered a compartment syndrome and meets criteria for abdominal compartment syndrome in advanced cases. For this reason, management of OHSS should include reduction of pressure by paracentesis to avoid morbidity and syndrome progression. In addition, measurement of IAP may help to classify the stage of OHSS. CONCLUSION(S): IAP was found to be elevated in the few cases of OHSS in which it was measured, substantiating the conclusion that OHSS may be considered a compartment syndrome. An understanding of the pathophysiology of increased intrabdominal pressure is useful in the management of OHSS. Copyright (c) 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 19836016      PMCID: PMC3124341          DOI: 10.1016/j.fertnstert.2009.07.1662

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  68 in total

1.  Prevention of the abdominal compartment syndrome.

Authors:  J C Mayberry
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

Review 2.  Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Int J Fertil Womens Med       Date:  2002 Sep-Oct

Review 3.  Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures.

Authors:  M A Aboulghar; R T Mansour
Journal:  Hum Reprod Update       Date:  2003 May-Jun       Impact factor: 15.610

4.  A simple technique to accurately determine intra-abdominal pressure.

Authors:  T J Iberti; K M Kelly; D R Gentili; S Hirsch; E Benjamin
Journal:  Crit Care Med       Date:  1987-12       Impact factor: 7.598

5.  Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome.

Authors:  Ishai Levin; Benny Almog; Amiram Avni; Amiram Baram; Joseph B Lessing; Ronni Gamzu
Journal:  Fertil Steril       Date:  2002-05       Impact factor: 7.329

6.  Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy.

Authors:  M A Aboulghar; R T Mansour; G I Serour; M A Sattar; Y M Amin; I Elattar
Journal:  Obstet Gynecol       Date:  1993-01       Impact factor: 7.661

7.  Thromboembolic phenomena after ovarian stimulation with human gonadotrophins.

Authors:  M Mozes; H Bogokowsky; E Antebi; B Lunenfeld; E Rabau; D M Serr; A David; M Salomy
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

8.  Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment.

Authors:  E Rabau; A David; D M Serr; S Mashiach; B Lunenfeld
Journal:  Am J Obstet Gynecol       Date:  1967-05-01       Impact factor: 8.661

Review 9.  Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

Authors:  D Navot; P A Bergh; N Laufer
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

10.  Distinction between early and late ovarian hyperstimulation syndrome.

Authors:  R S Mathur; A V Akande; S D Keay; L P Hunt; J M Jenkins
Journal:  Fertil Steril       Date:  2000-05       Impact factor: 7.329

View more
  16 in total

1.  GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.

Authors:  Yannis Prapas; Konstantinos Ravanos; Stamatios Petousis; Yannis Panagiotidis; Achilleas Papatheodorou; Chrysoula Margioula-Siarkou; Assunta Iuliano; Giuseppe Gullo; Nikos Prapas
Journal:  J Assist Reprod Genet       Date:  2017-08-03       Impact factor: 3.412

2.  Assessing the Usefulness of Severity Markers in Women with Ovarian Hyperstimulation Syndrome.

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova
Journal:  Reprod Sci       Date:  2020-10-15       Impact factor: 3.060

3.  Weight gain after in vitro fertilization: a potential consequence of controlled ovarian stimulation.

Authors:  Simar S Bajaj; Bhav Jain; Fatima Cody Stanford
Journal:  J Assist Reprod Genet       Date:  2022-02-26       Impact factor: 3.357

4.  A case of severe ovarian hyperstimulation syndrome.

Authors:  Moushumi Lodh; Jheelam Mukhopadhyay; Vikas Sharma
Journal:  Indian J Clin Biochem       Date:  2013-10-08

Review 5.  Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.

Authors:  Kelly Comerford Wormer; Ayesha A Jangda; Farah A El Sayed; Katherine I Stewart; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-19       Impact factor: 2.435

6.  GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes.

Authors:  Micah J Hill; Rebecca J Chason; Mark D Payson; James H Segars; John M Csokmay
Journal:  Reprod Biomed Online       Date:  2012-05-23       Impact factor: 3.828

Review 7.  The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models.

Authors:  Eric T Siegel; Hyung-Goo Kim; Hiromi Koso Nishimoto; Lawrence C Layman
Journal:  Reprod Sci       Date:  2012-11-26       Impact factor: 3.060

Review 8.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

9.  Management of ovarian hyperstimulation syndrome with abdominal compartment syndrome, based on intravesical pressure measurement.

Authors:  Hiroshi Makino; Tatsuro Furui; Tomomi Shiga; Motoki Takenaka; Keiko Terazawa; Ken-Ichiro Morishige
Journal:  Reprod Med Biol       Date:  2016-11-30

10.  Ovarian hyperstimulation syndrome as an etiology of obstructive uropathy.

Authors:  Creticus P Marak; Amit Chopra; Narendrakumar Alappan; Ana M Ponea; Achuta K Guddati
Journal:  Case Rep Obstet Gynecol       Date:  2013-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.